Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease

Cleveland Clinic Journal of Medicine

Volumn 75, Issue 7, 2008, Pages 521-530

  Blevins, Steve M ^a   Greenfield, Ronald A ^a   Bronze, Michael S ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BABESIOSIS; BLOOD; CHAGAS DISEASE; DIAGNOSIS, MEASUREMENT AND ANALYSIS; EHRLICHIOSIS; FEVER; HUMAN; MALARIA; MICROBIOLOGY; REVIEW; RISK FACTOR; TREATMENT FAILURE;

BABESIOSIS; CHAGAS DISEASE; EHRLICHIOSIS; FEVER; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MALARIA; RISK FACTORS; TREATMENT FAILURE;

EID: 51249108723     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.75.7.521     Document Type: Review

References (78)

1. Kroft SH. infectious diseases manifested in the peripheral blood. Clin Lab Med 2002; 22:253-277.
2. Meldrum SC, Birkhead GS, White DJ, Benach JL, Morse DL. Human babesiosis in New York State: an epidemiological description of 136 cases. Clin Infect Dis 1992; 15:1019-1023.
3. Pruthi RK, Marshall WF, Wiltsie JC, Parsing DH. Human babesiosis. Mayo Clin Proc 1995; 70:853-862.
4. Eskow ES, Krause PJ, Spielman A, Freeman K, Aslanzadeh J. Southern extension of the range of human babesiosis in the eastern United States. J Clin Microbiol 1999; 37:2051-2052.
5. Quick RE, Herwaldt BL, Thomford JW, et al. Babesiosis in Washington State: a new species of Babesia? Ann Intern Med 1993; 119:284-290.
6. Persing DH, Herwaldt BL, Glaser C, et al. Infection with a babesia-like organism in northern California. N Engl J Med 1995; 332:298-303.
7. Gorenflot A, Moubri K, Precigout E, Carcy B, Schetters TP. Human babesiosis. Ann Trop Med Parasitol 1998; 92:489-501.
8. Villar BF, White DJ, Benach JL. Human babesiosis. Prog Clin Parasitol 1991; 2:129-143.
9. Sun T, Tenenbaum MJ, Greenspan J, et al. Morphologic and clinical observations in human infection with Babesia micrati. J Infect Dis 1983; 148:239-248.
10. Benach JL, Habicht GS. Clinical characteristics of human babesiosis. J Infect Dis 1981; 144:481.
11. Boustani MR, Gelfand JA. Babesiosis. Clin Infect Dis 1996; 22:611-615.
12. Meer-Scherrer L, Adelson M, Mordechai E, Lottaz B, Tilton R. Babesia microti infection in Europe. Curr Microbiol 2004; 48:435-437.
13. Krause PJ. Babesiosis diagnosis and treatment. Vector Borne Zoonotic Dis 2003: 3:45-51.
14. Persing DH, Mathiesen D, Marshall WF, et al. Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol 1992; 30:2097-2103.
15. Chisholm ES, Sulzer AI, Ruebush TK 2nd. indirect immunofluorescence test for human Babesia microti infection: antigen specificity. Am J Trop Med Hyg 1986; 35:921-925.
16. Berry A, Morassin B, Kamar N, Magnaval JF. Clinical picture: human babesiosis. Lancet 2001; 357:341.
17. Maeda K, Markowitz N, Hawley R, Ristic M, Cox D, McDade JE. Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med 1987; 316:853-856.
18. Chen SM, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytotrophic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994; 32:589-595.
19. Lockhart JM, Davidson WR, Stallknecht DE, Dawson JE, Howerth EW. Isolation of Ehrlichia chaffeensis from wild white-tailed deer ( Odocoileus virginianus) confirms their role as natural reservoir hosts. J Clin Microbiol 1997; 35:1681-1686.
20. Stone JH, Dierberg K, Aram G, Dumler JS. Human monocytic erhlichiosis. JAMA 2004; 292:2263-2270.
21. Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis 2000; 31:554-560.
22. Dumler JS, Bakken JS. Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis 1995; 20:1102-1110.
23. Everett ED, Evans KA, Henry RB, McDonald G. Human ehrlichiosis in adults after tick exposure. Diagnosis using polymerase chain reaction. Ann Intern Med 1994; 120:730-735.
24. Fishbein DB, Dawson JE, Robinson LE. Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med 1994; 120:736-743.
25. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996; 275:199-205.
26. Ratnasamy N, Everett ED, Roland WE, McDonald G, Caldwell CW. Central nervous system manifestations of human ehrlichiosis. Clin Infect Dis 1996; 23:314-319.
27. Vanek NN, Kazi S, Cepero NM, Tang S, Rex JH. Human ehrlichiosis causing left ventricular dilation and dysfunction. Clin Infect Dis 1996; 22:386-387.
28. Bakken JS, Aguero-Rosenfeld ME, Tilden RL, et al. Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis. Clin Infect Dis 2001; 32:862-870.
29. Hamilton KS, Standaert SM, Kinney MC. Characteristic peripheral blood findings in human ehrlichiosis. Mod Path 2004; 17:512-517.
30. Dawson JE, Fishbein DB, Eng TR, Redus MA, Green NR. Diagnosis of human ehrlichiosis with the indirect fluorescent antibody test: kinetics and specificity. J Infect Dis 1990; 162:91-95.
31. Walls JJ, Caturegii P, Bakken JS, Asanovich KM, Dumler JS. improved sensitivity of PCR for diagnosis of human granulocytic ehrlichiosis using epank1 genes of Ehrlichia phagocytophila-group ehrlichiae. J Clin Microbiol 2000; 38:354-356.
32. Barbour AG. Relapsing fever. In: Goodman JL, Dennis DT, Sonenshine DE, editors. Tick-Borne Diseases of Humans. Washington, DC: ASM Press; 2005:268.
33. Barbour AG, Hayes SF. Biology of Borrelia species. Microbiol Rev 1986; 50:381-400.
34. Hoogstraal H. Ticks and spirochetes. Acta Trop 1979; 36:133-136.
35. Sonenshine D. Biology of Ticks. New York, NY: Oxford University Press; 1991.
36. Felsenfeld O. Borrelia; Strains, Vectors, Human, and Animal Borreliosis. St Louis, MO: Warren H Greene, Inc; 1971.
37. Bryceson AD, Parry EH, Perine PL, Warrell DA, Vukotich D, Leithead CS. Louse-borne relapsing fever. Q J Med 1970; 39:129-170.
38. Judge DM, Samuel I, Perine PL, Vukotic D, Ababa A. Louse-borne relapsing fever in man. Arch Pathol 1974; 97:136-170.
39. Southern P, Sanford J. Relapsing fever. A clinical and microbiological review. Medicine 1969; 48:129-149.
40. Barbour AG. Antigenic variation of a relapsing fever Borrelia species. Annu Rev Microbiol 1990; 44:155-171.
41. Stoenner HG, Dodd T, Larsen C. Antigenic variation of Borrelia. hermsii. J Exp Med 1982; 156:1297-1311.
42. Barbour AG. Immunobiology of relapsing fever. Contrib Microbiol Immunol 1987; 8:125-137.
43. Scott R. Neurological complications of relapsing fever. Lancet 1944; 247:436-438.
44. Cadavid D, Barbour AG. Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis 1998; 26:151-164.
45. Wengrower D, Knobler H, Gillis S, Chajek-Shaul T. Myocarditis in tick-borne relapsing fever. J Infect Dis 1984; 149:1033.
46. Perine PL, Parry EH, Vukotich D, Warrell DA, Bryceson AD. Bleeding in louse-borne relapsing fever. I. Clinical studies in 37 patients. Trans R Soc Trop Med Hyg 1971; 65:776-781.
47. Rhee KY, Johnson WD. Borrelia species (relapsing fever). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2005:2795-2798.
48. Greenwood BM, Bojang K, Whitty CJ, Targett GA. Malaria. Lancet 2005; 365:1487-1498.
49. Newbold C, Craig A, Kyes S, Rowe A, Fernandez-Reyes D, Fagan T. Cytoadherence, pathogenesis and the infected red cell surface in Plasmodium falciparum. Int J Parasitol 1999; 29:927-937.
50. Oh SS, Chishti AH, Palek J, Liu SC. Erythrocyte membrane alterations in Plasmodium, falciparum malaria sequestration. Curr Opin Hematol 1997; 4:148-154.
51. Singh B, Kim Sung L, Matusop A, et al. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet 2004; 363:1017-1024.
52. Fairhurst RM, Wellems TE. Plasmodium species (malaria). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2005:3121,3122.
53. Filler S, Causer LM, Newman RD, et al; Centers for Disease Control and Prevention (CDC). Malaria surveillance - United States, 2001. MMWR Surveill Summ 2003; 52:1-14.
54. Oillaro P, Cattani J, Wirth D. Malaria, the submerged disease. JAMA 1996; 275:230-233.
55. Kain KC, Keystone JS. Malaria in travelers. Epidemiology, disease, and prevention. Infect Dis Clin North Am 1998; 12:267-284.
56. World Health Organization, Division of Contirol of Tropical Diseases. Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990; 84(suppl 2):1-65.
57. Field JW. Blood examination and prognosis in acute falciparum malaria. Trans R Soc Trop Med Hyg 1949; 43:33-48.
58. Microscopic procedures for diagnosing malaria. Appendix. MMWR Surveill Summ 2003; 52:15-16.
59. Lema OE, Carter JY, Nagelkerke N, et al. Comparison of five methods of malaria detection in the outpatient setting. Am J Trop Med Hyg 1999; 60:177-182.
60. White NJ. The treatment of malaria. N Engl J Med 1996; 335:800-806.
61. Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev 2002; 15:66-78.
62. Makier MT, Palmer CJ, Ager AL. A review of practical techniques for the diagnosis of malaria. Ann Trop Med Parasitol 1998; 92:419-433.
63. Kirchhoff LV. Trypanosoma species (American trypanosomiasis, Chagas' disease): Biology of trypanosomes. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2005:3157-3158.
64. Barrett MR Burchmore RJ, Stich A, et al. The trypanosomiases. Lancet 2003; 362:1469-1480.
65. Chagas disease. Interruption of transmission. Wkly Epidemiol Rec 1997; 71:1
66. Control of Chagas disease. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1991; 811:1-95.
67. Kirchhoff LV. American trypanosomiasis (Chagas' disease). In: Guerrant R, Walker DH, Weller PF, editors. Tropical Infectious Diseases: Principles, Pathogens and Practicq; vol. 1. Philadelphia, PA: Churchill Livingstone; 1999:785.
68. Kirchhoff LV. American trypanosomiasis (Chagas' disease). Gastroenterol Clin North Am 1996; 25:517-533.
69. Wanderley DM, Corrêa FM. Epidemiology of Chagas' heart disease. Sao Paul Med J 1995; 113:742-749.
70. Schmuñis GA. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries. Transfusion 1991; 31:547-557.
71. Köberle F. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv Parasitol 1968; 6:63-116.
72. Dias E, Laranja FS, Miranda A, Nobrega G. Chagas' disease; a clinical, epidemiologic, and pathologic study. Circulation 1956; 14:1035-1060.
73. Prate A, Andrade Z, Guimaraes AC. Chagas' heart disease. In: Shaper AG, Hutt MS, Fejfar Z, editors. Cardiovascular disease in the tropics. London, England: British Medical Association; 1974:264.
74. Dias JC. The indeterminate form of human chronic Chagas' disease. A clinical epidemiological study. Rev Soc Bras Med Trop 1989; 22:147-156.
75. Lopes ER, Tafuri WL. Involvement of the autonomic nervous system in Chagas' heart disease. Rev Soc Bras Med Trop 1983; 16:206.
76. Meneghelli UG. Chagas' disease: a model of denervation tion in the study of digestive tract motility. Braz J Mad Biol Res 1985; 18:255-264.
77. Pirard M, Iihoshl N, Boelaert M, Basanta P, Lopez F, Van der Stuyft F. The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperenclemic region. Transfusion 2005; 45:554-561.
78. Kirchhoff LV. Trypanosoma species (American trypanosomiasis, Chagas' disease): Biology of trypanosomes. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2005:3162-3163.